Pharmacy benefit managers were paid by drugmakers, including Purdue Pharma, to keep opioid prescriptions flowing even as overdose deaths soared across the U.S., according to an investigation by The New York Times.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
